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The complexity of COPD and 
medication adherence 
Key learning points:
u  Patients with COPD may also suffer from other conditions, such as anxiety disorders, 
cardiac disease or diabetes
u  Tobacco smoking is recognised as the most common cause of COPD, so smoking 
cessation may be one way of successfully managing the condition
u  Between 20% and 50% of COPD patients are non-adherent, the main problem being 
misunderstanding medication
C
hronic obstructive pulmonary disease (COPD) 
is recognised as one of the most common 
respiratory diseases in the UK, with over 5 
million people diagnosed.1,2 Maintaining 
'quality of life' is dependent on a range of 
care, including prescribed medication. 
However, studies from the 1990s and more 
recent research identify that those diagnosed with COPD 
often struggle to manage their medication due to a 
range of health-related problems.
COPD co-morbidities can comprise a range 
of conditions such as anxiety disorders or 
those of organ function, for example cardiac 
disease or diabetes. However, the manage-
ment of the co-morbidity can also affect the 
person’s COPD and vice versa. These further 
complexities add to the overall pharmacologi-
cal burden. Moreover, there is little guidance 
for the health professional on the most appropri-
ate choice of medication delivery.
MeDIcATIoN ADhereNce 
Medication compliance and adherence is a major component in 
COPD care.3 The nurse is key in screening and monitoring these 
patients and the role is recognised as increasingly important in 
supporting the role of the physician and providing continuity of 
care4,5 – in particular health promotion and patient education.6 The 
community nurse is often able to view at fi rst hand some of the 
COPD patient’s daily challenges, which may shed light on reasons 
for non-compliance. 
It is recognised that suboptimal medication levels impact 
adversely on the patient and also generally on healthcare 
expenditure. Braido et al7 identifi ed compliancy as something that 
involves a defi nite decision on the part of the person to accept their 
condition and their management. 
However, the issues surrounding COPD as a whole can be 
complex. In the arena of poor compliance, a whole raft of other 
elements may be identifi ed, such as personal limitations caused by 
the disease – ageing processes, poor cognition abilities, anxiety 
states and depression.8 Other factors may include a 
reduced belief in the effi cacy of the medication, 
underestimation of the severity of the condition 
and tobacco smoking.9 
Tobacco smoking is recognised as the 
commonest cause of COPD. The evidence 
for nurse-led smoking cessation pro-
grammes has shown positive results.10 
However, for many people smoking is part of 
their social construct; an activity that provides 
pleasure, relaxation and helps relieve tension.11 
Therefore, successfully managing COPD may 
include a person making multiple lifestyle changes 
such as smoking cessation and starting an exercise 
regime as well as medication adherence – but this may be 
hard to achieve in some.12 
MeDIcATIoN MIsMANAGeMeNT 
Studies from the late 1990s demonstrated that up to 90% of 
patients with inhaled medications were not using their inhaler 
devices correctly.13,14 
Dry powder inhalers (DPIs) and pressurised metered dose 
inhalers (pMDIs) are the most commonly used delivery systems for 
dispensing aerosol drugs and are recommended at all stages of 
treatment. Worldwide they are the most frequently prescribed 
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device, and are considered the cornerstone of COPD manage-
ment.15 These plus adjunctive therapies such as smoking cessation 
and oxygen and drug therapy have long been recognised as 
mainstays of COPD treatment.16,17 
However, the management of COPD is multifaceted, due to the 
long-term and changing nature of the disease, which can also 
include periods of remission. Also, COPD is often associated with 
multiple comorbidities, which may require other medications, 
administered by varying routes. 
Furthermore, differing disease combinations can prompt 
changes to medication regimes – which can influence an individual’s 
adherence.18 
COPD is a long-term condition and a study by the WHO in 2003 
estimated that there is a 50% adherence or less for patients taking 
medications over a long period, with the improper use of medication 
being more frequent in those over 65, especially when coupled with 
polypharmacy.19 Prescribing appropriately and accommodating 
some of the problems faced by patients requires a holistic assess-
ment to identify potential problems that may affect adherence.20 
However, there is little advice on inhaler selection in prescribing 
guidelines. 
Therefore the primary focus could be on medication choice, not 
the patient’s ability to use the inhaler.21 
Between 20% and 50% of patients with COPD are considered to 
be non-adherent. The main problem is medication being under-
used.22,23 There is also the problem of polypharmacy and improper 
use of medication delivery, which increases in patients over 65. 
Problems include a lack of understanding of how the medication 
device functions, incorrect inhaler technique and difficulties in 
handling the inhaler, which may be attributable to poor co-ordination 
between inspiration and inhaler activation.24 A combination of these 
elements is considered to be particularly common in the older age 
group or those with advanced lung damage. 
The inhalation force is another major aspect in compliance. 
Manufacturers recommend a ‘deep and hard’ inhalation, which 
allows a fast acceleration rate and allows the formulation of the 
metered dose to break into particles that enter the inspired airstream 
and deposit in the lungs.25 However, the level of resistance in the 
inhaler device, coupled with the level of COPD obstruction can affect 
the rate of flow. Therefore, patients with severe COPD are not always 
able to achieve fast inhalation rates.26 Incorrect use of pMDIs, 
especially in those not using a spacer, and failure to co-ordinate 
inspiration with actuation results in a reduced deposition in the lung. 
A significant correlation has been identified between a patient’s 
satisfaction with their device and their level of compliance. A poor 
inhaler technique has been linked to increased use of reliever 
medication and also to a rise in the use of emergency services, 
which demonstrates the importance of patient support and good 
technique.27,28 
A change in device can also be a cause of poor compliance. 
With this in mind, the European Respiratory Society has recom-
mended that patients remain on their current inhaler regime if their 
disease is stable.29
The Nurse’s role
The primary care nurse has an important role in supporting the 
patient at all stages from initial diagnosis to end-of-life care. 
“The community nurse is often 
able to view at first hand some 
of the challenges that a COPD 
patient may experience on a 
daily basis”
“90% of patients with  
inhaled medications are  
not using their inhaler 
devices correctly”
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However, although the literature contains information on the 
reactive aspects of COPD care, there is little about proactive 
management. It has been noted that health professionals may fail to 
recognise non-adherence and might instead attribute symptom 
changes to other causes.23 
This is not surprising, as COPD can be highly complex and 
encompass periods of exacerbation and remission. In many cases, 
the symptoms might include mental health problems such as 
depression. 
The literature supports the view that ’strong’ education 
initiatives enable patients to manage their medication more 
effectively. 
However, due to the changing nature of COPD, it could be 
considered that some medication regimes can be just as complex 
as the condition itself. 
In 2008, the Department of Health made a case in its paper the 
NHS Next Stage Review for high-quality community care that 
encourages patient empowerment and self-management. Likewise 
NICE guidelines (2010) and the Five-Year Forward View (2014)30 
identified the role of the multi-disciplinary team in COPD manage-
ment.31,32 
The team includes the primary care nurse, whose assessment 
and care coordination skills have been described as invaluable in 
providing advice, education and support to prevent inappropriate 
hospital admissions. 
This supports the view that the primary care nurse is well 
placed to identify and respond, to enable a patient to ‘do better’ in 
a condition that is progressive and incurable.33,34,35 
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